US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Izotropic Corp
(CSE:
IZO
)
0.1400
UNCHANGED
Delayed Quote
Updated: 3:45 PM EDT, Oct 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Izotropic Corp
< Previous
1
2
3
Next >
Izotropic Completes Pre-Submission Meeting With U.S. FDA
November 01, 2023
VANCOUVER, BC, November 1, 2023 – TheNewswire – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Izotropic Confirms FDA Pre-Submission Meeting Date
September 27, 2023
Vancouver, BC - TheNewswire - September 27, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Izotropic Closes Non-Brokered Private Placement
September 20, 2023
Vancouver, BC - TheNewswire - September 20, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQ: IZOZF) (FSE: 1R3), a medical device company commercializing IzoView, a CT...
Via
TheNewswire.com
Izotropic Corporation Announces Non-Brokered Private Placement
September 13, 2023
Vancouver, BC - TheNewswire - September 13, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
September 06, 2023
Via
TheNewswire.com
Izotropic Engages Market Awareness Consultant
June 27, 2023
VANCOUVER, BC – TheNewswire - JUNE 27, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a 360-degree...
Via
TheNewswire.com
Izotropic Modifies Market Approval Pathway & Strategy
June 20, 2023
VANCOUVER, BC – TheNewswire - JUNE 20, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a 360-degree...
Via
TheNewswire.com
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration
May 15, 2023
VANCOUVER, BC – TheNewswire - May 15, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast...
Via
TheNewswire.com
Izotropic Provides Business Update
April 27, 2023
VANCOUVER, BC – TheNewswire - April 27, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast...
Via
TheNewswire.com
Izotropic to Extend Period for Unsecured Loans
March 29, 2023
Vancouver, BC - TheNewswire - March 29, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast...
Via
TheNewswire.com
Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA
January 13, 2023
VANCOUVER, BC – TheNewswire - January 13, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Creates Compensation Committee and Adopts Charter
January 12, 2023
Vancouver, BC - TheNewswire - January 12, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Releases First Video of IzoView
January 09, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Via
Newsfile
Izotropic Releases First Video of Izoview
January 09, 2023
VANCOUVER, BC – TheNewswire - January 9, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Reports Board Meeting Results
January 04, 2023
VANCOUVER, BC – TheNewswire - January 4, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Delays Announcements to 2023, Holds Board Meeting
December 28, 2022
VANCOUVER, BC – TheNewswire - December 28, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
December 20, 2022
VANCOUVER, BC – TheNewswire - December 20, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Completes Izoview Development and Assembly, Prepares for Final Testing
December 01, 2022
VANCOUVER, BC – TheNewswire – December 1 , 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Alexander Tokman Joins Izotropic Board Of Directors
November 11, 2022
VANCOUVER, BC – TheNewswire - November 11, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Topics
Artificial Intelligence
IZOTROPIC CORPORATION Announces Closing of Non-Brokered Private Placement
November 10, 2022
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
Via
TheNewswire.com
Izotropic Grants Stock Options
November 01, 2022
VANCOUVER, BC – TheNewswire - November 1, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
June 30, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Via
Newsfile
Topics
Intellectual Property
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
June 03, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or...
Via
Newsfile
Topics
Supply Chain
Izotropic Provides Corporate Update
May 27, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 27, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Via
Newsfile
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
April 20, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or...
Via
Newsfile
< Previous
1
2
3
Next >